NFG
BEAM icon

Next Financial Group’s Beam Therapeutics BEAM Stock Holding History

Next Financial Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Buy
+6
New +$514 ﹤0.01% 2863

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Next Financial Group's BEAM Position: Q4 2021 in Review

Next Financial Group opened a new position in Beam Therapeutics (BEAM) in Q4 2021: 6 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2863 among its holdings.

232 funds tracked by Wall St. Rank hold BEAM as of Q4 2021.

  • Next Financial Group held 6 shares of Beam Therapeutics worth $0 as of Q4 2021.
  • Beam Therapeutics was a new Next Financial Group position in Q4 2021.
  • Beam Therapeutics made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2863 holding.
  • 232 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.